When is the expected fda decision date for apotex's ruxolitinib resubmission?

What FDA decision date is expected for Apotex’s ruxolitinib resubmission?

The expected FDA decision date for Apotex’s ruxolitinib resubmission is not provided in the available information I have here, so I can’t state a specific date.

Where to check the expected date (and what to look for)

To find the exact “target action date” / expected FDA decision date for a specific ruxolitinib resubmission, you would typically check:
- FDA’s Drugs@FDA entries for the specific application (and any associated submission updates), and/or
- Any publicly posted FDA status materials tied to that application.

If you want, share the product name, application type (for example, NDA/ANDA), or the FDA submission/application identifier you’re looking at, and I can help you pinpoint where that expected decision date would appear.

Sources: None.